Cronos Group, Inc. (CRON)
3.08
-0.09
(-2.84%)
USD |
NASDAQ |
Nov 19, 16:00
3.075
0.00 (0.00%)
After-Hours: 20:00
Cronos Group Price : 3.08 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 3.175 | 3.189 | 3.04 | 3.08 | 1.491M |
| Nov 18, 2026 | 3.19 | 3.27 | 3.17 | 3.17 | 1.130M |
| Nov 17, 2026 | 3.26 | 3.28 | 3.19 | 3.19 | 837035.0 |
| Nov 16, 2026 | 3.36 | 3.37 | 3.253 | 3.27 | 943655.0 |
| Nov 13, 2026 | 3.42 | 3.43 | 3.34 | 3.38 | 722862.0 |
| Nov 12, 2026 | 3.45 | 3.46 | 3.385 | 3.41 | 939418.0 |
| Nov 11, 2026 | 3.41 | 3.48 | 3.36 | 3.45 | 1.073M |
| Nov 10, 2026 | 3.52 | 3.56 | 3.41 | 3.41 | 1.045M |
| Nov 09, 2026 | 3.66 | 3.765 | 3.54 | 3.54 | 1.482M |
| Nov 06, 2026 | 3.70 | 3.705 | 3.55 | 3.61 | 1.316M |
| Nov 05, 2026 | 3.71 | 3.91 | 3.60 | 3.72 | 3.971M |
| Nov 04, 2026 | 3.45 | 3.57 | 3.435 | 3.51 | 2.119M |
| Nov 03, 2026 | 3.36 | 3.46 | 3.34 | 3.38 | 1.125M |
| Nov 02, 2026 | 3.32 | 3.396 | 3.31 | 3.33 | 1.010M |
| Oct 30, 2026 | 3.35 | 3.358 | 3.265 | 3.30 | 1.091M |
| Oct 29, 2026 | 3.35 | 3.390 | 3.32 | 3.36 | 666416.0 |
| Oct 28, 2026 | 3.375 | 3.38 | 3.32 | 3.35 | 536170.0 |
| Oct 27, 2026 | 3.30 | 3.395 | 3.30 | 3.38 | 751460.0 |
| Oct 26, 2026 | 3.370 | 3.41 | 3.295 | 3.31 | 827875.0 |
| Oct 23, 2026 | 3.425 | 3.43 | 3.30 | 3.35 | 816805.0 |
| Oct 22, 2026 | 3.39 | 3.465 | 3.372 | 3.445 | 995558.0 |
| Oct 21, 2026 | 3.30 | 3.445 | 3.265 | 3.39 | 1.147M |
| Oct 20, 2026 | 3.26 | 3.31 | 3.25 | 3.28 | 885500.0 |
| Oct 19, 2026 | 3.21 | 3.27 | 3.20 | 3.25 | 788362.0 |
| Oct 16, 2026 | 3.23 | 3.355 | 3.205 | 3.21 | 865945.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Lexaria Bioscience Corp. | 4.49 |
| Target Group, Inc. (Canada) | 0.0008 |
| XORTX Therapeutics, Inc. | 0.89 |
| NervGen Pharma Corp. | 1.92 |
| Milestone Pharmaceuticals, Inc. | 0.3993 |
Price Related Metrics
| PE Ratio | 20.00 |
| PS Ratio | 5.639 |
| PEG Ratio | 0.3083 |
| Price to Book Value | 1.056 |
| Price to Free Cash Flow | 17.98 |
| Earnings Yield | 5.00% |
| Market Cap | 1.132B |
| PEGY Ratio | 0.3083 |
| Operating PE Ratio | 116.20 |
| Normalized PE Ratio | 18.58 |